By Adam Bonislawski
Research published this week by a team including scientists from proteomics firm Cellzome and GlaxoSmithKline suggests that the small molecule inhibitor I-BET151 could be useful as a treatment for MLL-fusion leukemia.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.
A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.
A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.
In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.